A recap of news you can use from the 2016 ACVIM Forum. The focus of this segment is on an emerging therapy for cats with diabetes mellitus and, possibly, obesity - specifically incretin-based therapies. Read more: http://vetvine.com/forums/topic/738/diabetes-and-obesity-future-treatment-options-are-promising Discussion includes: - Incretins: What they are and their biologic effects - Applications of incretin-based therapy including treatment of diabetes mellitus and obesity - Findings of pilot studies examining the effects of incretin-based therapies in cats including: Byetta®, Bydureon®, Victoza®, and a DPP-4 Inhibitor Running time: 8 minutes Member Fee: $14.95; Free registration for new Members, Unlimited Plus members, and Evidence Based Update subscribers http://vetvine.com/article/181/evidence-based-update-subscriptions)